INTERNATIONAL PATENT: KINIKSA PHARMACEUTICALS, GMBH FILES APPLICATION FOR "COMPOSITIONS COMPRISING HUMANIZED ANTI-CD40 ANTIBODIES AND METHODS FOR TREATING RHEUMATOID ARTHRITIS USING THE SAME"

GENEVA, March 9 -- KINIKSA PHARMACEUTICALS, GMBH (Grafenaustrasse 56302 Zug) filed a patent application (PCT/EP2024/073687) for "COMPOSITIONS COMPRISING HUMANIZED ANTI-CD40 ANTIBODIES AND METHODS FOR TREATING RHEUMATOID ARTHRITIS USING THE SAME" on Aug 23, 2024. With publication no. WO/2025/045766, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PAOLINI, John F. (100 Hayden Ave.Lexington, Massachusetts 02421), TESSARI, Eben (100 Hayden Ave.Lexington, Massachusetts 02421), JENKINS, Eric (100 Hayden Ave.Lexington, Massachus...